HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 1.530
  • -0.100-6.13%
Market Closed Sep 17 16:08 CST
1.96BMarket Cap-12644P/E (TTM)

CSTONE PHARMA-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-2.80%254.17M
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
--79.45M
--1.04B
----
----
Operating income
-2.80%254.17M
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
79.45M
1.04B
Cost of sales
23.97%-82.14M
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
---31.22M
---241.42M
----
----
Operating expenses
23.97%-82.14M
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
-31.22M
-241.42M
Gross profit
12.12%172.03M
9.31%304.3M
-9.23%153.44M
103.36%278.38M
250.46%169.04M
-82.83%136.89M
48.23M
797.41M
Selling expenses
52.25%-62.77M
39.09%-199.35M
10.19%-131.45M
10.03%-327.3M
-9.56%-146.35M
-155.92%-363.79M
-455.33%-133.58M
---142.15M
---24.06M
----
Administrative expenses
47.67%-46.67M
26.64%-182.71M
33.84%-89.19M
16.31%-249.06M
12.52%-134.82M
13.11%-297.6M
6.73%-154.11M
-0.30%-342.51M
1.55%-165.23M
-78.79%-341.48M
Research and development expenses
64.53%-66.25M
14.06%-527.8M
29.95%-186.77M
52.94%-614.16M
48.00%-266.63M
7.10%-1.3B
5.77%-512.75M
-0.65%-1.4B
-41.87%-544.15M
-64.15%-1.4B
Special items of operating profit
-45.26%27.71M
1,293.92%250.15M
151.54%50.62M
120.30%17.95M
203.48%20.12M
30.79%-88.42M
-131.15%-19.45M
77.63%-127.75M
109.12%62.43M
24.06%-571.04M
Operating profit
111.83%24.05M
60.25%-355.42M
43.30%-203.35M
53.38%-894.2M
53.52%-358.63M
-57.24%-1.92B
-15.00%-771.65M
47.16%-1.22B
45.70%-671.01M
-28.72%-2.31B
Financing cost
-42.13%-8.35M
-39.42%-11.82M
-100.07%-5.87M
-278.10%-8.48M
-33.64%-2.94M
-69.85%-2.24M
-823.11%-2.2M
-335.64%-1.32M
-59.73%-238K
---303K
Earning before tax
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
After-tax profit from continuing operations
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
Earning after tax
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
Profit attributable to shareholders
107.50%15.7M
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-32.27%-2.31B
Basic earnings per share
105.88%0.01
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
Diluted earnings per share
105.88%0.01
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -2.80%254.17M-3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M--79.45M--1.04B--------
Operating income -2.80%254.17M-3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M79.45M1.04B
Cost of sales 23.97%-82.14M21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M---31.22M---241.42M--------
Operating expenses 23.97%-82.14M21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M-31.22M-241.42M
Gross profit 12.12%172.03M9.31%304.3M-9.23%153.44M103.36%278.38M250.46%169.04M-82.83%136.89M48.23M797.41M
Selling expenses 52.25%-62.77M39.09%-199.35M10.19%-131.45M10.03%-327.3M-9.56%-146.35M-155.92%-363.79M-455.33%-133.58M---142.15M---24.06M----
Administrative expenses 47.67%-46.67M26.64%-182.71M33.84%-89.19M16.31%-249.06M12.52%-134.82M13.11%-297.6M6.73%-154.11M-0.30%-342.51M1.55%-165.23M-78.79%-341.48M
Research and development expenses 64.53%-66.25M14.06%-527.8M29.95%-186.77M52.94%-614.16M48.00%-266.63M7.10%-1.3B5.77%-512.75M-0.65%-1.4B-41.87%-544.15M-64.15%-1.4B
Special items of operating profit -45.26%27.71M1,293.92%250.15M151.54%50.62M120.30%17.95M203.48%20.12M30.79%-88.42M-131.15%-19.45M77.63%-127.75M109.12%62.43M24.06%-571.04M
Operating profit 111.83%24.05M60.25%-355.42M43.30%-203.35M53.38%-894.2M53.52%-358.63M-57.24%-1.92B-15.00%-771.65M47.16%-1.22B45.70%-671.01M-28.72%-2.31B
Financing cost -42.13%-8.35M-39.42%-11.82M-100.07%-5.87M-278.10%-8.48M-33.64%-2.94M-69.85%-2.24M-823.11%-2.2M-335.64%-1.32M-59.73%-238K---303K
Earning before tax 107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B
After-tax profit from continuing operations 107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B
Earning after tax 107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B
Profit attributable to shareholders 107.50%15.7M59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-32.27%-2.31B
Basic earnings per share 105.88%0.0162.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39
Diluted earnings per share 105.88%0.0162.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data